GE HealthCare Exceeds Q2 Earnings Estimates with Record Orders
GE HealthCare (NASDAQ:GEHC) reported second-quarter results that beat Wall Street expectations, driven by record order growth and strong revenue performance. The company's adjusted earnings per share came in at $1.13 versus the expected $1.04, while revenue rose 5.7% year-over-year to $5.3 billion against forecasts of $5.26 billion. Despite overall strength, GE HealthCare’s Patient Care Solutions segment saw a 13.5% decline in revenue due to ongoing challenges and higher costs for memory chips, oil, and freight. The company's order backlog increased to $23.9 billion with a book-to-bill ratio of 1.15 times. GE HealthCare reaffirmed its full-year guidance, projecting organic revenue growth between 3% and 4%, an adjusted EBIT margin in the range of 15.4%–15.7%, and free cash flow around $1.6 billion for 2026.
Tickers: $GEHC